Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12976
CALL
Vinci Compass Investments Ltd
VINP
$626M
| $10.9K | ﹤0.01% |
1,000
-600
| -38% | -$6.47K |
|
12977
PUT
Lyell Immunopharma
LYEL
$342M
| $10.9K | ﹤0.01% |
375
+80
| +27% | +$3.81K |
|
|
PDM
12978
PUT
Piedmont Realty Trust
PDM
$1.19B
| $10.9K | ﹤0.01% |
1,500
-3,500
| -70% | -$24.3K |
|
12979
CALL
Civista Bancshares
CIVB
$593M
| $10.8K | ﹤0.01% |
700
+500
| +250% | +$7.26K |
|
12980
PUT
Sutro Biopharma
STRO
$340M
| $10.8K | ﹤0.01% |
370
+130
| +54% | +$5.14K |
|
|
KC
12981
CALL
Kingsoft Cloud Holdings
KC
$3.51B
| $10.8K | ﹤0.01% |
4,300
-13,000
| -75% | -$38.4K |
|
12982
CALL
Puma Biotechnology
PBYI
$456M
| $10.8K | ﹤0.01% |
3,300
-102,200
| -97% | -$449K |
|
|
FEED
12983
ENvue Medical Inc
FEED
$4.06M
| $10.8K | ﹤0.01% |
140
+43
| +44% | +$3.66K |
|
12984
iHeartMedia
IHRT
$457M
| $10.7K | ﹤0.01% |
9,849
-267,532
| -96% | -$417K |
|
12985
Pentair
PNR
$10.6B
| $10.7K | ﹤0.01% |
+140
| New | +$11.3K |
|
12986
CALL
Zedge
ZDGE
$38.4M
| $10.7K | ﹤0.01% |
3,500
-5,100
| -59% | -$13.8K |
|
12987
PUT
Sight Sciences
SGHT
$448M
| $10.7K | ﹤0.01% |
1,600
-1,600
| -50% | -$9.46K |
|
12988
PUT
Brilliant Earth
BRLT
$22.5M
| $10.7K | ﹤0.01% |
4,800
-4,000
| -45% | -$10.1K |
|
12989
CALL
Organogenesis Holdings
ORGO
$230M
| $10.6K | ﹤0.01% |
3,800
-6,600
| -63% | -$17.7K |
|
12990
CALL
RPC Inc
RES
$1.41B
| $10.6K | ﹤0.01% |
1,700
-2,900
| -63% | -$20.3K |
|
12991
PUT
MaxCyte
MXCT
$136M
| $10.6K | ﹤0.01% |
2,700
+600
| +29% | +$2.58K |
|
12992
PUT
Liberty Latin America Class A
LILA
$1.69B
| $10.6K | ﹤0.01% |
1,619
-8,391
| -84% | -$46.7K |
|
12993
CALL
Equity Bancshares
EQBK
$1.06B
| $10.6K | ﹤0.01% |
+300
| New | +$10K |
|
12994
PUT
ESCO Technologies
ESE
$7.92B
| $10.5K | ﹤0.01% |
100
-400
| -80% | -$42.2K |
|
|
SCWX
12995
PUT
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $10.5K | ﹤0.01% |
1,500
+1,400
| +1,400% | +$8.6K |
|
12996
Northann Corp
NCL
| $10.5K | ﹤0.01% |
5,509
+1,600
| +41% | +$5.27K |
|
12997
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $10.5K | ﹤0.01% |
100
-100
| -50% | -$10.5K |
|
12998
PUT
DHI Group
DHX
$171M
| $10.4K | ﹤0.01% |
5,000
-4,800
| -49% | -$11.1K |
|
|
NXTS
12999
Nexentis Technologies
NXTS
$2.78M
| $10.4K | ﹤0.01% |
+89
| New | +$20.7K |
|
13000
CALL
Invesco BuyBack Achievers ETF
PKW
$1.8B
| $10.4K | ﹤0.01% |
100
-3,700
| -97% | -$385K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.